Revenue Summary of AtriCure, Inc.

AtriCure, Inc.'s latest annual revenue in 2023 was 399.24 Million USD , up 20.84% from previous year.
AtriCure, Inc.'s latest quarterly revenue in 2024 Q3 was 115.91 Million USD , down -0.31% from previous quarter.
AtriCure, Inc. reported a annual revenue of 330.37 Million USD in annual revenue 2022, up 20.43% from previous year.
AtriCure, Inc. reported a annual revenue of 274.32 Million USD in annual revenue 2021, up 32.83% from previous year.
AtriCure, Inc. reported a quarterly revenue of 116.26 Million USD for 2024 Q2, up 6.81% from previous quarter.
AtriCure, Inc. reported a quarterly revenue of 115.91 Million USD for 2024 Q3, down -0.31% from previous quarter.

Annual Revenue Chart of AtriCure, Inc. (2023 - 2001)

Historical Annual Revenue of AtriCure, Inc. (2023 - 2001)

Year	Revenue	Revenue Growth
2023	399.24 Million USD	20.84%
2022	330.37 Million USD	20.43%
2021	274.32 Million USD	32.83%
2020	206.53 Million USD	-10.52%
2019	230.8 Million USD	14.47%
2018	201.63 Million USD	15.4%
2017	174.71 Million USD	12.64%
2016	155.1 Million USD	19.54%
2015	129.75 Million USD	20.75%
2014	107.45 Million USD	31.22%
2013	81.88 Million USD	16.57%
2012	70.24 Million USD	9.08%
2011	64.4 Million USD	9.15%
2010	59 Million USD	8.2%
2009	54.53 Million USD	-1.31%
2008	55.25 Million USD	14.38%
2007	48.3 Million USD	26.32%
2006	38.24 Million USD	23.54%
2005	30.95 Million USD	61.6%
2004	19.15 Million USD	95.64%
2003	9.79 Million USD	454.47%
2002	1.76 Million USD	8730.0%
2001	20 Thousand USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	108.85 Million USD	2.17%
2024 Q2	116.26 Million USD	6.81%
2024 Q3	115.91 Million USD	-0.31%
2023 Q1	93.49 Million USD	6.21%
2023 Q4	106.54 Million USD	8.4%
2023 FY	399.24 Million USD	20.84%
2023 Q2	100.91 Million USD	7.94%
2023 Q3	98.29 Million USD	-2.6%
2022 Q2	84.52 Million USD	13.35%
2022 Q3	83.24 Million USD	-1.52%
2022 Q4	88.02 Million USD	5.74%
2022 FY	330.37 Million USD	20.43%
2022 Q1	74.57 Million USD	1.85%
2021 Q3	70.46 Million USD	-1.28%
2021 Q1	59.27 Million USD	2.69%
2021 Q2	71.37 Million USD	20.42%
2021 FY	274.32 Million USD	32.83%
2021 Q4	73.21 Million USD	3.91%
2020 Q4	57.72 Million USD	5.42%
2020 FY	206.53 Million USD	-10.52%
2020 Q1	53.22 Million USD	-13.2%
2020 Q2	40.82 Million USD	-23.3%
2020 Q3	54.75 Million USD	34.13%
2019 FY	230.8 Million USD	14.47%
2019 Q2	58.9 Million USD	9.15%
2019 Q3	56.61 Million USD	-3.89%
2019 Q4	61.32 Million USD	8.31%
2019 Q1	53.96 Million USD	2.03%
2018 Q2	51.8 Million USD	10.23%
2018 FY	201.63 Million USD	15.4%
2018 Q4	52.89 Million USD	5.91%
2018 Q3	49.94 Million USD	-3.59%
2018 Q1	46.99 Million USD	2.02%
2017 Q2	45.23 Million USD	9.59%
2017 Q1	41.27 Million USD	0.28%
2017 FY	174.71 Million USD	12.64%
2017 Q4	46.06 Million USD	9.28%
2017 Q3	42.15 Million USD	-6.81%
2016 Q3	38.34 Million USD	-3.36%
2016 Q1	35.94 Million USD	0.21%
2016 FY	155.1 Million USD	19.54%
2016 Q2	39.67 Million USD	10.38%
2016 Q4	41.15 Million USD	7.35%
2015 Q2	32.58 Million USD	9.02%
2015 FY	129.75 Million USD	20.75%
2015 Q3	31.42 Million USD	-3.56%
2015 Q4	35.86 Million USD	14.13%
2015 Q1	29.88 Million USD	1.6%
2014 Q1	24.84 Million USD	13.54%
2014 FY	107.45 Million USD	31.22%
2014 Q2	26.51 Million USD	6.71%
2014 Q4	29.41 Million USD	10.26%
2014 Q3	26.67 Million USD	0.62%
2013 Q2	20.42 Million USD	5.14%
2013 Q1	19.43 Million USD	5.8%
2013 Q4	21.88 Million USD	8.63%
2013 Q3	20.14 Million USD	-1.39%
2013 FY	81.88 Million USD	16.57%
2012 Q3	16.13 Million USD	-11.65%
2012 Q4	18.36 Million USD	13.79%
2012 Q2	18.26 Million USD	4.53%
2012 FY	70.24 Million USD	9.08%
2012 Q1	17.47 Million USD	4.25%
2011 Q1	15.63 Million USD	-4.59%
2011 Q4	16.76 Million USD	10.13%
2011 FY	64.4 Million USD	9.15%
2011 Q3	15.22 Million USD	-9.28%
2011 Q2	16.77 Million USD	7.31%
2010 Q4	16.38 Million USD	13.24%
2010 Q2	14.19 Million USD	1.72%
2010 Q3	14.47 Million USD	1.98%
2010 Q1	13.95 Million USD	1.1%
2010 FY	59 Million USD	8.2%
2009 Q1	13.67 Million USD	13.32%
2009 Q4	13.8 Million USD	3.91%
2009 Q3	13.28 Million USD	-3.6%
2009 Q2	13.77 Million USD	0.76%
2009 FY	54.53 Million USD	-1.31%
2008 Q3	14.8 Million USD	-0.38%
2008 FY	55.25 Million USD	14.38%
2008 Q1	13.53 Million USD	2.88%
2008 Q2	14.85 Million USD	9.82%
2008 Q4	12.06 Million USD	-18.48%
2007 Q1	10.75 Million USD	1.43%
2007 FY	48.3 Million USD	26.32%
2007 Q2	12.35 Million USD	14.9%
2007 Q4	13.15 Million USD	9.1%
2007 Q3	12.05 Million USD	-2.41%
2006 FY	38.24 Million USD	23.54%
2006 Q1	8.63 Million USD	0.91%
2006 Q2	9.64 Million USD	11.72%
2006 Q3	9.35 Million USD	-3.02%
2006 Q4	10.59 Million USD	13.26%
2005 Q3	7.16 Million USD	-7.25%
2005 Q4	8.55 Million USD	19.38%
2005 Q1	7.49 Million USD	30.84%
2005 FY	30.95 Million USD	61.6%
2005 Q2	7.73 Million USD	3.1%
2004 FY	19.15 Million USD	95.64%
2004 Q4	5.73 Million USD	27.34%
2004 Q2	5.12 Million USD	0.0%
2004 Q3	4.49 Million USD	-12.19%
2003 FY	9.79 Million USD	454.47%
2002 FY	1.76 Million USD	8730.0%
2001 FY	20 Thousand USD	0.0%

Peer Revenue Comparison of AtriCure, Inc.

Name	Revenue	Revenue Difference
Akoya Biosciences, Inc.	96.63 Million USD	-313.156%
AngioDynamics, Inc.	303.91 Million USD	-31.368%
Avinger, Inc.	7.65 Million USD	-5117.525%
Azenta, Inc.	665.07 Million USD	39.97%
BioLife Solutions, Inc.	143.27 Million USD	-178.664%
The Cooper Companies, Inc.	3.59 Billion USD	88.889%
Daxor Corporation	1.28 Million USD	-31078.471%
Ekso Bionics Holdings, Inc.	18.27 Million USD	-2084.173%
Femasys Inc.	1.07 Million USD	-37144.046%
GlucoTrack, Inc.	- USD	-Infinity%
Harvard Bioscience, Inc.	112.25 Million USD	-255.675%
Hologic, Inc.	4.03 Billion USD	90.094%
ICU Medical, Inc.	2.25 Billion USD	82.327%
Intuitive Surgical, Inc.	7.12 Billion USD	94.396%
KORU Medical Systems, Inc.	28.51 Million USD	-1299.992%
LeMaitre Vascular, Inc.	193.48 Million USD	-106.345%
Innovative Eyewear, Inc.	1.15 Million USD	-34542.28%
Innovative Eyewear, Inc.	1.15 Million USD	-34542.28%
Masimo Corporation	2.04 Billion USD	80.507%
Microbot Medical Inc.	- USD	-Infinity%
Meihua International Medical Technologies Co., Ltd.	97.09 Million USD	-311.173%
Merit Medical Systems, Inc.	1.25 Billion USD	68.248%
Nephros, Inc.	14.23 Million USD	-2704.081%
NovoCure Limited	509.33 Million USD	21.615%
NEXGEL, Inc.	4.08 Million USD	-9663.879%
NEXGEL, Inc.	4.08 Million USD	-9663.879%
Singular Genomics Systems, Inc.	2.91 Million USD	-13615.046%
OraSure Technologies, Inc.	405.47 Million USD	1.536%
Pro-Dex, Inc.	53.84 Million USD	-641.485%
Pulse Biosciences, Inc.	- USD	-Infinity%
Predictive Oncology Inc.	1.78 Million USD	-22328.323%
Precision Optics Corporation, Inc.	19.1 Million USD	-1989.812%
QuidelOrtho Corporation	2.99 Billion USD	86.682%
Repligen Corporation	638.76 Million USD	37.497%
Sanara MedTech Inc.	64.98 Million USD	-514.319%
STAAR Surgical Company	322.41 Million USD	-23.83%
Sharps Technology, Inc.	- USD	-Infinity%
Utah Medical Products, Inc.	50.22 Million USD	-694.929%
DENTSPLY SIRONA Inc.	3.96 Billion USD	89.931%
Jin Medical International Ltd.	19.82 Million USD	-1914.206%

Global Stocks Search

AtriCure, Inc. (ATRC)

Revenue Summary of AtriCure, Inc.

Annual Revenue Chart of AtriCure, Inc. (2023 - 2001)

Historical Annual Revenue of AtriCure, Inc. (2023 - 2001)

Peer Revenue Comparison of AtriCure, Inc.